Health Bulletin 13/June/2023

Published On 2023-06-13 10:59 GMT   |   Update On 2023-06-13 10:59 GMT
Advertisement

Here are the top health stories for the day:


Why can't medical college reports be made public? Transparency woes plague NMC

While the apex medical regulator, the National Medical Commission (NMC) has been denying recognition to several medical colleges across the country due to inadequate infrastructure, the controversy regarding the medical college assessment reports and the demands to make them public have escalated further.

Advertisement

With media reports suggesting that around 40 medical colleges have lost their recognition and several more might face the same fate in the coming time, the question that bothers aspirants and medical students is which one and why.

For more details, check out the link given below:

Why Can't Medical College Reports be Made Public? Transparency Woes Plague NMC


50 new medical colleges approved across country this year, none in Kerala

While the Union Ministry of Health and Family Welfare (MoHFW) recently announced that 50 new medical colleges have been added in the country, none of these medical colleges have been added in the State of Kerala.

Medical Dialogues had earlier reported that in a major boost to undergraduate medical education in India, altogether 50 new medical colleges have been approved this year with an intake capacity of 8,195 MBBS seats.

For more details, check out the link given below:

50 New Medical Colleges approved across country this year, None in Kerala


Monitor endometrioma size of clinical trial participants: CDSCO panel tells Abbott India on Dydrogesterone

Suggesting monitoring the size of the endometrioma of participating subjects during the clinical trial, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted approval to the drug major Abbott India to conduct the Phase III clinical trial and bioequivalence (BE) study of Dydrogesterone Sustained Release Tablets 20mg, an orally active progestogen that acts directly on the uterus, producing a complete secretory endometrium in an estrogen-primed uterus.

For more details, check out the link given below:

Monitor endometrioma size of clinical trial participants: CDSCO panel tells Abbott India on Dydrogesterone

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News